• Guideline Summary
  • NGC:009801
  • 2013 Apr

Pirfenidone for treating idiopathic pulmonary fibrosis.

  • Guideline Summary
  • NGC:009154
  • 2012 May 10

Best evidence statement (BESt). Sleep promotion in children with mental health diagnoses.

  • Guideline Summary
  • NGC:010011
  • 2013 Aug

Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy.

  • Guideline Summary
  • NGC:010861
  • 2015 Nov 25

Apremilast for treating moderate to severe plaque psoriasis.

  • Guideline Summary
  • NGC:009800
  • 2013 April

Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures.

  • Guideline Summary
  • NGC:009073
  • 2003 Oct (revised 2012 Apr)

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia (part review of technology appraisal guidance 70).

  • Guideline Summary
  • NGC:009893
  • 2013 May

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.

  • Guideline Summary
  • NGC:009997
  • 2010 Aug (revised 2013 Jul)

Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.

  • Guideline Summary
  • NGC:009332
  • 2007 Jun (revised 2012 Sep)

Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122).